iCAD, Inc.

NASDAQ:ICAD

1.78 (USD) • At close December 24, 2024
Bedrijfsnaam iCAD, Inc.
Symbool ICAD
Munteenheid USD
Prijs 1.78
Beurswaarde 47,241,200
Dividendpercentage 0%
52-weken bereik 1.18 - 2.65
Industrie Medical Devices
Sector Healthcare
CEO Ms. Dana R. Brown
Website https://www.icadmed.com

An error occurred while fetching data.

Over iCAD, Inc.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image

Vergelijkbare Aandelen

Axcella Health Inc. logo

Axcella Health Inc.

AXLA

4.58 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

APTO

0.25 USD

DURECT Corporation logo

DURECT Corporation

DRRX

0.97 USD

Ardelyx, Inc. logo

Ardelyx, Inc.

ARDX

4.64 USD

Aeglea BioTherapeutics, Inc. logo

Aeglea BioTherapeutics, Inc.

AGLE

12.01 USD

LAVA Therapeutics N.V. logo

LAVA Therapeutics N.V.

LVTX

0.975 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)